The relationship between cognitive change and physical health and behavioural outcomes in a Ugandan cohort of adults living with HIV – a longitudinal study

References

• Applebaum, A. J., Reilly, L. C., Gonzalez, J. S., Richardson, M. A., Leveroni, C. L., & Safren, S. A. (2009). The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. AIDS Patient Care and STDs, 23(6), 455–462. doi: 10.1089/apc.2008.0181
   PubMed Web of Science ®Google Scholar
• Becker, B. W., Thames, A. D., Woo, E., Castellon, S. A., & Hinkin, C. H. (2011). Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS and Behavior, 15(8), 1888–1894. doi: 10.1007/s10461-011-9924-z
   PubMed Web of Science ®Google Scholar
• Berhan, A., & Berhan, Y. (2012). Is the sexual behaviour of HIV patients on antiretroviral therapy safe or risky in Sub-Saharan Africa? Meta-analysis and meta-regression. AIDS Research and Therapy, 9(1), 1–9. doi:10.1186/1742-6405-9-14
   PubMedGoogle Scholar
• Berner, K., Morris, L., Baumeister, J., & Louw, Q. (2017). Objective impairments of gait and balance in adults living with HIV-1 infection: A systematic review and meta-analysis of observational studies. BMC Musculoskeletal Disorders, 18(1), 1–26. doi:10.1186/s12891-017-1682-2
   PubMedGoogle Scholar
• Carballo, E., Cadarso-Suarez, C., Carrera, I., Fraga, J., de la Fuente, J., Ocampo, A., … Prieto, A. (2004). Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 13(3), 587–599. doi: 10.1023/B:QURE.0000021315.93360.8b
   PubMed Web of Science ®Google Scholar
• Cysique, L. A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S. P., … Ellis, R. J. (2009). Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73(5), 342–348. doi: 10.1212/WNL.0b013e3181ab2b3b
   PubMed Web of Science ®Google Scholar
• Dikmen, S. S., Heaton, R. K., Grant, I., & Temkin, N. R. (1999). Test-retest reliability and practice effects of expanded Halstead–Reitan neuropsychological test battery. Journal of the International Neuropsychological Society, 5(4), 346–356. doi: 10.1017/S1355617799544056
   PubMed Web of Science ®Google Scholar
• Eaton, L. A., & Kalichman, S. C. (2009). Changes in transmission risk behaviors across stages of HIV disease among people living with HIV. The Journal of the Association of Nurses in AIDS Care, 20(1), 39–49. doi: 10.1016/j.jana.2008.10.005
   PubMed Web of Science ®Google Scholar
• Ettenhofer, M. L., Hinkin, C. H., Castellon, S. A., Durvasula, R., Ullman, J., Lam, M., … Foley, J. (2009). Aging, neurocognition, and medication adherence in HIV infection. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 17(4), 281–290. doi: 10.1097/JGP.0b013e31819431bd
   PubMed Web of Science ®Google Scholar
• Habib, A. G., Yakasai, A. M., Owolabi, L. F., Ibrahim, A., Habib, Z. G., Gudaji, M., … Nashabaru, I. (2013). Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: A systematic review and meta-analysis. International Journal of Infectious Diseases: Official Publication of the International Society for Infectious Diseases, 17(10), e820–e831. doi: 10.1016/j.ijid.2013.06.011
   PubMed Web of Science ®Google Scholar
• Heaton, R. K., Clifford, D. B., Franklin Jr., D. R., Woods, S. P., Ake, C., Vaida, F., … Group, C. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology, 75(23), 2087–2096. doi: 10.1212/WNL.0b013e318200d727
   PubMed Web of Science ®Google Scholar
• Hernández Huerta, D., Parro Torres, C., Madoz Gúrpide, A., Ochoa Mangado, E., & Pérez Elias, M. J. (2016). Relationship between executive functions and adherence to antiretroviral therapy in HIV-infected patients. European Psychiatry, 33(Suppl.), S368–S369. doi: 10.1016/j.eurpsy.2016.01.1321
   Google Scholar
• Hunt, P. W., Deeks, S. G., Rodriguez, B., Valdez, H., Shade, S. B., Abrams, D. I., … Martin, J. N. (2003). Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS (London, England), 17(13), 1907–1915. doi:10.1097/01.aids.0000076342.42412.82 doi: 10.1097/00002030-200309050-00009
   PubMed Web of Science ®Google Scholar
• Imaz, A., Olmo, M., Penaranda, M., Gutierrez, F., Romeu, J., Larrousse, M., … Podzamczer, D. (2013). Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function. Antiviral Therapy, 18(1), 125–130. doi: 10.3851/IMP2249
   PubMed Web of Science ®Google Scholar
• Insel, K., Morrow, D., Brewer, B., & Figueredo, A. (2006). Executive function, working memory, and medication adherence among older adults. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 61(2), P102–P107. doi: 10.1093/geronb/61.2.P102
   PubMed Web of Science ®Google Scholar
• Kinyanda, E., Levin, J., Nakasujja, N., Birabwa, H., Nakku, J., Mpango, R., … Patel, V. (2018). Major depressive disorder: Longitudinal analysis of impact on clinical and behavioural outcomes in Uganda. Journal of Acquired Immune Deficiency Syndromes 1999, 136–143. doi:10.1097/QAI.0000000000001647
   Google Scholar
• Ko, S., Hausdorff, J. M., & Ferrucci, L. (2010). Age-associated differences in the gait pattern changes of older adults during fast-speed and fatigue conditions: Results from the Baltimore longitudinal study of ageing. Age and Ageing, 39(6), 688–694. doi: 10.1093/ageing/afq113
   PubMed Web of Science ®Google Scholar
• Lopez, O. L., Smith, G., Meltzer, C. C., & Becker, J. T. (1999). Dopamine systems in human immunodeficiency virus-associated dementia. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 12(3), 184–192.
   PubMedGoogle Scholar
• Nakimuli-Mpungu, E., Mutamba, B., Othengo, M., & Musisi, S. (2009). Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: A pilot study. African Health Sciences, 9(Suppl. 1), S2–S7.
   PubMed Web of Science ®Google Scholar
• Odili, V. U., Obieche, A. O., & Amibor, K. C. (2017). Adherence to antiretroviral therapy and its determinants among HIV-infected patients in Nigeria. Journal of Pharmacy Practice, 30(3), 291–295. doi: 10.1177/0897190016633978
   PubMedGoogle Scholar
• Parsons, T. D., Braaten, A. J., Hall, C. D., & Robertson, K. R. (2006). Better quality of life with neuropsychological improvement on HAART. Health and Quality of Life Outcomes, 4, 1–7. doi:10.1186/1477-7525-4-11
   PubMed Web of Science ®Google Scholar
• Patel, R., Kassaye, S., Gore-Felton, C., Wyshak, G., Kadzirange, G., Woelk, G., & Katzenstein, D. (2009). Quality of life, psychosocial health, and antiretroviral therapy among HIV-positive women in Zimbabwe. AIDS Care, 21(12), 1517–1527. doi: 10.1080/09540120902923055
   PubMed Web of Science ®Google Scholar
• Powderly, W. G. (2002). Sorting through confusing messages: The art of HAART. Journal of Acquired Immune Deficiency Syndromes (1999), 31(Suppl. 1), S3–S9. Discussion S24–5. doi: 10.1097/00126334-200209011-00002
   PubMedGoogle Scholar
• Reepalu, A., Balcha, T. T., Skogmar, S., Jemal, Z. H., Sturegard, E., Medstrand, P., & Bjorkman, P. (2014). High rates of virological suppression in a cohort of human immunodeficiency virus-positive adults receiving antiretroviral therapy in Ethiopian health centers irrespective of concomitant tuberculosis. Open Forum Infectious Diseases, 1(1), 1–8. doi:10.1093/ofid/ofu039
   Google Scholar
• Robertson, K. R., Nakasujja, N., Wong, M., Musisi, S., Katabira, E., Parsons, T. D., … Sacktor, N. (2007). Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurology, 7, 8–14. doi: 10.1186/1471-2377-7-8
   PubMed Web of Science ®Google Scholar
• Robertson, K. R., Parsons, T. D., Sidtis, J. J., Hanlon Inman, T., Robertson, W. T., Hall, C. D., & Price, R. W. (2006). Timed gait test: Normative data for the assessment of the AIDS dementia complex. Journal of Clinical and Experimental Neuropsychology, 28(7), 1053–1064. doi: 10.1080/13803390500205684
   PubMed Web of Science ®Google Scholar
• Rubin, L. H., Maki, P. M., Springer, G., Benning, L., Anastos, K., Gustafson, D., … Valcour, V. G. (2017). Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression. Neurology, 89(15), 1594–1603. doi: 10.1212/WNL.0000000000004491
   PubMed Web of Science ®Google Scholar
• Saylor, D., Dickens, A. M., Sacktor, N., Haughey, N., Slusher, B., Pletnikov, M., … McArthur, J. C. (2016). HIV-associated neurocognitive disorder – pathogenesis and prospects for treatment. Nature Reviews. Neurology, 12(4), 234–248. doi: 10.1038/nrneurol.2016.27
   PubMed Web of Science ®Google Scholar
• Solomon, T. M., & Halkitis, P. N. (2008). Cognitive executive functioning in relation to HIV medication adherence among gay, bisexual, and other men who have sex with men. AIDS and Behavior, 12(1), 68–77. doi: 10.1007/s10461-007-9273-0
   PubMed Web of Science ®Google Scholar
• Stilley, C. S., Bender, C. M., Dunbar-Jacob, J., Sereika, S., & Ryan, C. M. (2010). The impact of cognitive function on medication management: Three studies. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association, 29(1), 50–55. doi: 10.1037/a0016940
   PubMed Web of Science ®Google Scholar
• Ugbena, R., Aberle-Grasse, J., Diallo, K., Bassey, O., Jelpe, T., Rottinghaus, E., … Yang, C. (2012). Virological response and HIV drug resistance 12 months after antiretroviral therapy initiation at 2 clinics in Nigeria. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 54(Suppl. 4), S375–S380. doi: 10.1093/cid/cir1064
   PubMedGoogle Scholar
• UNAIDS. (2017). UNAIDS Data 2017. Retrieved from http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf
   Google Scholar
• World Health Organization. (2007). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Retrieved from http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf?ua=1
   Google Scholar